Inner Ear Gene Therapy in Hearing loss - Expanding Boundaries
Description of the granted funding
Untreated hearing loss (HL) causes considerable difficulties in daily communication and can adversely affect academic performance, quality of life, and social and emotional functioning, particularly in children. For those who suffer from hearing loss caused by genetic etiologies, gene therapy (GT) might offer a more suitable solution than the conventional methods used today. This project aims to design, test, and advance the inner ear GT in a farm pig and disease model pig (Usher syndrome type 1) for clinical practice. This project develops novel methods and vectors for GT to further test and create a treatment strategy for Usher syndrome type 1 in disease model pigs to be used in clinical studies in the future. The project will be carried out in multinational collaboration with the top centers in Europe; Kuopio University Hospital amd University of Eastern Filand (Finland), MUV (Austria), The Technical University of Munich (TUM), Germany and Pasteur Institute, Paris, France.
Show moreStarting year
2025
End year
2029
Granted funding
Funder
Research Council of Finland
Funding instrument
Clinical researcher
Decision maker
Scientific Council for Biosciences, Health and the Environment
16.06.2025
16.06.2025
Other information
Funding decision number
369801
Fields of science
Genetics, developmental biology, physiology
Research fields
Perinnöllisyystiede